The use of G-CSF in normal neutrophil donors

Annales de Medecine Interne

Volumn 151, Issue 2, 2000, Pages 115-122

  Price, Thomas H ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

G CSF; Neutrophil transfusion

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BONE MARROW TRANSPLANTATION; BONE PAIN; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FATIGUE; HEADACHE; HEMATOPOIESIS; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MYALGIA; NAUSEA; NEUTROPENIA; NEUTROPHIL; REVIEW; TREATMENT OUTCOME;

GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; NEUTROPHILS; TISSUE DONORS; TISSUE PRESERVATION;

EID: 0034120417     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. PIZZO PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med, 1993; 328: 1323-32.
2. HUGHES WT, ARMSTRONG D, BODEY GP, BROWN AE, EDWARDS JE, FELD R, et al.: 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis, 1997; 25: 551-73.
3. DALE DC, LILES WC, PRICE TH: Renewed interest in granulocyte transfusion therapy. Br J Haematol, 1997; 98: 497-501.
4. THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS STUDY GROUP: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med, 1997; 337: 1861-9.
5. PANNUTI C, GINGRICH R, PFALLER MA, KAO C, WENZEL RP: Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer, 1992; 69: 2653-62.
6. IWEN PC, REED EC, ARMITAGE JO, BIERMAN PJ, KESSINGER A, VOSE JM, et al.: Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol, 1993; 14: 131-9.
7. SAUGIER-VEBER P, DEVERGIE A, SULAHIAN A, RIBAUD P, TRAORE F, BOURDEAU-ESPEROU H, et al.: Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant, 1993; 12: 121-4.
8. HIGBY DJ, YATES JW, HENDERSON ES, HOLLAND JF: Filtration leukapheresis for granulocyte transfusion therapy: clinical and laboratory studies. N Engl J Med, 1975; 292: 761-6.
9. HERZIG RH, HERZIG GP, GRAW RG, BULL MI, RAY KK: Successful granulocyte transfusion therapy for gram-negative septicemia: a prospectively randomized controlled study. N Engl J Med, 1977; 296: 701-5.
10. VOGLER WR, WINTON EF: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med, 1977; 63: 548-55.
11. GRAW RG, HERZIG GH, PERRY S, HENDERSON ES: Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med, 1972; 287: 367-71.
12. ALAVI JB, ROOT RK, DJERASSI I, EVANS AE, GLUCKMAN SJ, MACGREGOR RR, et al.: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med, 1977; 296: 706-11.
13. WINSTON DJ, HO WG, GALE RP: Therapeutic granulocyte transfusions for documented infections: a controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med, 1982; 97: 509-15.
14. FORTUNY IE, BLOOMFIELD CD, HADLOCK DC, GOLDMAN A, KENNEDY BJ, MCCULLOUGH JJ: Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion, 1975; 15: 548-57.
15. KARP DD, ERVIN TJ, TUTTLE S, GORGONE BC, LAVIN P, YUNIS EJ: Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang, 1982; 42: 57-61.
16. WRIGHT DG, ROBICHAUD KJ, PIZZO PA, DEISSEROTH AB: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med, 1981; 304: 1185-9.
17. DALE DC, LILES WC, SUMMER WR, NELSON S: Review: granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis, 1995; 172: 1061-75.
18. COLOTTA F, RE F, MANTOVANI A: Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: also a question of cell survival? Blood, 1993; 82: 2258.
19. DANCEY JT, DEUBELBEISS KA, HARKER LA, FINCH CA: Neutrophil kinetics in man. J Clin Invest, 1976; 58: 705-15.
20. MORSE EE, FREIREICH EJ, CARBONE PP, BRONSON W, FREI III E: The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion, 1966; 6: 183-92.
21. LOWENTHAL RM, GROSSMAN L, GOLDMAN JM, STORRING RA, BUSKARD NA, PARK DS, et al.: Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anasmia. Lancet, 1975; 353-8.
22. STRAUSS RG: Therapeutic granulocyte transfusions in 1993. Blood, 1993; 81: 1675-8.
23. VAMVAKAS EC, PINEDA AA: Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis, 1996; 11: 1-9.
24. LAURENTI, FERRO R, ISACCHI G. PANERO A, SAVIGNONI PG, MALAGNINO F, et al.: Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr, 1981; 98: 118-23.
25. CAIRO MS, RUCKER R, BENNETTS GA, HICKS D, WORCESTER C, AMLIE RN, et al.: Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics, 1984; 74: 887-92.
26. CAIRO MS, WORCESTER C, RUCKER RW, HANTEN S, AMLIE RN, SENDER L, et al.: Randomized trail of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr, 1992; 120: 281-5.
27. CHRISTENSENS RD, ROTHSTEIN G, ANSTALL HB, BYBEE B: Granulocyle transfusions in neonates with bacterial infections, neutropenia, and depletion of mature marrow neutrophils. Pediatrics, 1982; 70: 1-6.
28. APPELBAUM FR, BOWLES CA, MAKUCH RW, DEISSEROTH AB: Granulocyte transfusion therapy of experimental pseudomonas septicemia: study of cell dose and collection technique. Blood, 1978; 52: 323-31.
29. EPSTEIN RB, CHOW HS: An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion, 1981; 21: 360-2.
30. HINCKLEY ME, HUESTIS DW: Premedication for optimal granulocyte collection. Plasma Therapy, 1981; 2: 149-52.
31. WINTON EF, VOGLER WR: Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator. Blood, 1978; 52: 249-53.
32. PRATI D, ZANELLA A, BOSONI P, REBULLA P, FARMA E, DE MATTEI C, et al.: The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients. Blood, 1998; 91: 774-7.
33. BRADLEY TR, METCALF D: The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci, 1966; 44: 287-94.
34. AVALOS BR: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood, 1996; 88: 61-77.
35. D'ANDREA AD: Cytokine receptors in congenital hematopoietic disease. N Eng J Med, 1994; 330: 839-46.
36. HAMMOND WP, CSIBA E, CANIN A, HOCKMAN H, SOUZA LM, LAYTON JE, et al.: Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin invest, 1991; 87: 704-10.
37. LIESCHKE GJ, GRAIL D, HODGSON G, METCALF D, STANLEY E, CHEERS C, et al.: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood, 1994; 84: 1737-46.
38. CHATTA GS, PRICE TH, ALLEN RC, DALE DC: Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood, 1994; 84: 2923-9.
39. PRICE TH, CHATTA GS, DALE DC: Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood, 1996; 88: 335-40.
40. LIESCHKE GJ, BURGESS AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. (first of two parts). N Engl J Med, 1992; 327: 28-35, 99-106.
41. LILES WC, HUANG JE, VAN BURIK JH, BOWDEN RA, DALE DC: Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis, 1997; 175: 1012-5.
42. GAVIRIA JM, VAN BURIK JA, DALE DC, ROOT RK, LILES WC: Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis, 1999; 179: 1038-41.
43. LILLES WC, RODGER ER, DALE DC: Differential regulation of human neutrophil surface expression of CD14, CD1 1b, CD18, and L-selection following the administration of G-CSF in vivo and in vitro. Clin Res, 1994; 42: 304A (Abstract).
44. STRONCEK DF, JASZCZ W, HERR GP, CLAY ME, MCCULLOUGH J: Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor. Tramfusion, 1998; 38: 663-8.
45. LILES WC: Regulation of apoptosis in neutrophils-Fast track to death? J Immunol, 1995; 155: 3289-91.
46. BENSINGER WI, PRICE TH, DALE DC, APPELBAUM FR, CLIFT R, LILLEBY K, et al.: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood, 1993; 81: 1883-8.
47. CASPAR CB, SEGER RA, BURGER J, GMÜR J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood, 1993; 81: 2866-71.
48. HESTER JP, DIGNANI MC, ANAISSIE EJ, KANTARJIAN HM, O'BRIEN S, FREIREICH EJ: Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis, 1995; 10: 188-93.
49. GRIGG A, VECCHI L, BARDY P, SZER J: G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med, 1996; 26: 813-8.
50. ADKINS D, SPITZER G, JOHNSTON M, VELASQUEZ W, DUNPHY F, PETRUSKA P: Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion, 1997; 37: 737-48.
51. JENDIROBA DB, LICHTIGER B, ANAISSIE E, REDDY V, O-BRIEN S, KANTARJIAN H, et al.: Evaluation and comparison of three mobilization methods for the collection of granulocytes. Transfusion, 1998; 38: 722-8.
52. LEITMAN SF, YU M, LEKSTROM J: Pair-controlled study of granulocyte colony stimulating factor (G-CSF) plus dexamethasone (DEXA) for granulocytapheresis donors. Transfusion, 1995; 35: 53S (Abstract).
53. LILES WC, HUANG JE, LLEWELLYN C, SENGUPTA D, PRICE TH, DALE DC: A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion, 1997; 37: 182-7.
54. DALE DC, LILES WC, LLEWELLYN C, RODGER E, PRICE TH: Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion, 1998; 38: 713-21.
55. ADKINS D, GOODGOLD H, HENDERSHOTT L, JOHNSTON M, CRAVENS D, SPTIZER G: Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant receipients. Bone Marrow Transplant, 1997; 19: 809-12.
56. BOWDEN R, PRICE T, BOECKH M, LILES C, CAYS M, DALE D: Phase I/II study of granulocyte transfusions from G-CSF-stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients. Blood, 1997; 90 suppl 1: 435A (Abstract).
57. PRICE TH, BOWDEN RA, BOECKH M, LILES WC, LLEWELLYN C, FULLER F, et al.: Neutrophil collection from community apheresis donors after granulocyte colony-stimulating factor and dexamethasone stimulation: feasibility and efficacy. Blood, 1997; 90 suppl 1: 137B (Abstract).
58. PRICE TH: Blood center perspective of granulocyte transfusions: future applications. J Clin Apheresis, 1995; 10: 119-23.
59. STRONCEK DF, CLAY ME, PETZOLDT ML, SMITH J, JASZCZ W, OLDHAM FB, et al.: Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells Transfusion, 1996; 36: 601-10.
60. ANDERLINI P, PRZEPIORKA D, SEONG D, MILLER P, SUNDBERG J, LICHTIGER B, et al.: Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion, 1996; 36: 590-5.
61. FUKUMOTO Y, MIYAMOTO T, OKAMURA T, GONDO H, IWASAKI H, HORIUCHI T, et al.: Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol, 1997; 97: 666-8.
62. BECKER PS, WAGLE M, MATOUS S, SWANSON RS, PIHAN G, LOWRY PA, et al.: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant, 1997; 3: 45-9.
63. BONILLA MA, DALE D, ZEIDLER C, LAST L, REITER A, RUGGEIRO M, et al.: Longterm safety of treatment with recombinant human granulocyte colony-stimulating factor (r-methHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol, 1994; 88: 723-30.
64. KALRA R, DALE D, FREEDMAN M, BONILLA MA, WEINBLATT M, GANSER A, et al.: Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood, 1995; 86: 4579-86.
65. TIDOW N, PILZ C, TEICHMANN B, MÜLLER-BRECHLIN A, GERMESHADSEN M, KASPER B, et al.: Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood, 1999; 89; 2369-75.
66. HUNTER MG, AVALOS BR: Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. Blood, 1999; 93: 440-6.
67. WARD AC, VAN AESCH YM, SCHELEN AM, TOUW IP: Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood, 1999; 93: 447-58.
68. LITAM PP, FRIEDMAN HD, LOUGHRAN TP: Splenic extramedullary hematopoiesis in a patient receiving intermittently administered granulocyte colony-stimulating factor. Ann Intern Med, 1993; 118: 954-5.
69. SANDOR V, HASSAN R, KOHM E: Exacerbation of pseudogout by granulocyte colony-stimulating factor. Ann Intern Med, 1996; 125: 781.
70. DE LUIS DA, ROMERO E: Reversible thyroid dysfunction with filgrastim. Lancet, 1996; 348: 1595-6.
71. SCHRIJVERS D, SLOOTMAEKERS V, DIRIX L, VAN OOSTEROM A: Neurological disturbances due to filgrastim. Lancet, 1997; 349: 402-3.
72. LEITMAN SF, OBLITAS JM, EMMONS R, DUNN DE, YOUNG NS: Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections. Blood, 1996; 88 suppl 1: 331A (Abstract).
73. CLARKE K, SZER J, SHELTON M, COGHLAN D, GRIGG A: Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection. Bone Marrow Transplant, 1995; 16: 723-6.
74. DI MARIO A, SICA S, SALUTARI P, LA BARBERA EO, MARRA R, LEONE G: Granulocyte colony-stimulating factor-primed leukocyte transfusions in Candida tropicalis fungemia in neutropenic patients. Haematologica, 1997; 82: 362-3.
75. VON PLANTA M, OZSAHIN H, SCHROTEN H, STAUFFER UG, SEGER RA: Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. Eur J Pediatr Surg, 1997; 7: 234-6.
76. CATALANO L, FONTANA R, SCARPATO N, PICARDI M, ROCCO S, ROTOLI B: Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. Haematologica, 1997; 82: 71-2.
77. TAYLOR K, MOORE D, KELLY C, WRIGHT S, RODWELL R, BASHFORD J, et al.: Safety and logistical use of filgrastim (FG) mobilised granulocytes (FMG) in early management of severe neutropenic sepsis (SNS) in acute leukemia (AL)/ autograft. Blood, 1996; 88 suppl 1: 349A (Abstract).
78. STRONCEK DF, LEONARD K, EIBER G, MALECH HL, GALLIN JI, LEITMAN SF: Alloimmunization after granulocyte transfusions. Transfusion, 1996; 36: 1009-15.